(Q43175072)
English
Late safety, efficacy, and cost-effectiveness of a zotarolimus-eluting stent compared with a paclitaxel-eluting stent in patients with de novo coronary lesions: 2-year follow-up from the ENDEAVOR IV trial (Randomized, Controlled Trial of the Medtron
scientific article published in December 2009
Statements
1 reference
Late safety, efficacy, and cost-effectiveness of a zotarolimus-eluting stent compared with a paclitaxel-eluting stent in patients with de novo coronary lesions: 2-year follow-up from the ENDEAVOR IV trial (Randomized, Controlled Trial of the Medtron (English)
1 reference
Kevin J Anstrom
1 reference
Jeffrey J Popma
1 reference
Ajay J Kirtane
1 reference
Donald E Cutlip
1 reference
Laura Mauri
1 reference
David E Kandzari
1 reference
Martin B Leon
1 reference
Brent T McLaurin
1 reference
Eugenia Nikolsky
1 reference
Paul A Overlie
1 reference
ENDEAVOR IV Investigators
1 reference
Eric L Eisenstein
1 reference
Charles O'Shaughnessy
1 reference
Stuart L Solomon
1 reference
John S Douglas
1 reference
1 December 2009
1 reference
1 reference
2
1 reference
12
1 reference
1208-1218
1 reference
Identifiers
1 reference
1 reference